Lan, X., Wang, H., Qi, R., Xu, Y., Yu, Y., Yang, Y., . . . Geng, L. (2020). Shikonin inhibits CEBPD downregulation in IL-17-treated HaCaT cells and in an imiquimod-induced psoriasis model. Mol Med Rep.
Style de citation ChicagoLan, Xiao-Ou, He-Xiao Wang, Rui-Qun Qi, Yuan-Yuan Xu, Ya-Jie Yu, Yang Yang, Hao Guo, Xing-Hua Gao, et Long Geng. "Shikonin Inhibits CEBPD Downregulation in IL-17-treated HaCaT Cells and in an Imiquimod-induced Psoriasis Model." Mol Med Rep 2020.
Style de citation MLALan, Xiao-Ou, et al. "Shikonin Inhibits CEBPD Downregulation in IL-17-treated HaCaT Cells and in an Imiquimod-induced Psoriasis Model." Mol Med Rep 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.